↓ Skip to main content

Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status

Overview of attention for article published in Parkinsonism & Related Disorders, February 2014
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
77 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status
Published in
Parkinsonism & Related Disorders, February 2014
DOI 10.1016/j.parkreldis.2014.02.001
Pubmed ID
Authors
Abstract

Apolipoprotein (APOE) e4 allele status has been linked to clinical presentation and progression in Alzheimer's disease; however, evidence for a role of APOE e4 in Parkinson's disease (PD) remains largely inconclusive. In this analysis we explored potential significant associations between APOE e4 allele status and characteristics of clinical presentation in patients with PD.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 1 1%
United Kingdom 1 1%
Unknown 75 97%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 13 17%
Student > Master 13 17%
Researcher 10 13%
Student > Bachelor 4 5%
Student > Doctoral Student 3 4%
Other 11 14%
Unknown 23 30%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 15 19%
Neuroscience 12 16%
Psychology 10 13%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Agricultural and Biological Sciences 4 5%
Other 7 9%
Unknown 25 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 January 2015.
All research outputs
#17,285,036
of 25,373,627 outputs
Outputs from Parkinsonism & Related Disorders
#2,095
of 3,100 outputs
Outputs of similar age
#207,356
of 329,736 outputs
Outputs of similar age from Parkinsonism & Related Disorders
#29
of 57 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,100 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 329,736 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.